Functional and Oncologic Outcomes Between Open and

Kvaliteten på radikal prostatektomi måste säkerställas

Sahlgrenska University Hospital, Gothenburg, Sweden, Search for more papers by this author. Antti S. Rannikko. Helsinki University Central Hospital Fritz H Schröder, Jonas Hugosson, Monique J Roobol, Teuvo L J Tammela, Stefano Ciatto, Vera Nelen, Maciej Kwiatkowski, Marcos Lujan, Hans Lilja, Marco Zappa, Louis J Denis, Franz Recker, The New England journal of medicine - 2009-01-01 SUBJECTS AND METHODS • In 1995, 20 000 men born between 1930 and 1944 were randomly selected from the population register and randomized to either a screening group (10 000), invited for total prostate‐specific antigen (tPSA) testing every second year until they reached an upper age‐limit pending between 67 and 71 years, or to a control group not invited (10 000). JONAS HUGOSSON , JOHAN STRANNE & SIGRID V. CARLSSON Institute of Clinical Sciences, Department of Urology, Sahlgrenska Academy at University of Gothenburg, Sweden Abstract Background.

By giving a grade of “D” in the recommendation statement that was based on this Björn Zackrisson 1 , Gunnar Aus, Hans Lilja, Pär Lodding, Carl-Gustaf Pihl, Jonas Hugosson Affiliation 1 Department of Urology, Sahlgrenska University Hospital, Göteborg, Sweden. bjorn.zackrisson@lundbysjukhus.se Jonas Hugosson. Sahlgrenska University Hospital, Gothenburg, Sweden, Search for more papers by this author. Antti S. Rannikko. Helsinki University Central Hospital This study is a substudy within the major prostate cancer screening trial that has been running in Gothenburg since 1995 under the direction of Jonas Hugosson of Sahlgrenska Academy, University of Fritz H Schröder, Jonas Hugosson, Monique J Roobol, Teuvo L J Tammela, Stefano Ciatto, Vera Nelen, Maciej Kwiatkowski, Marcos Lujan, Hans Lilja, Marco Zappa, Louis J Denis, Franz Recker, The New England journal of medicine - 2009-01-01 SUBJECTS AND METHODS • In 1995, 20 000 men born between 1930 and 1944 were randomly selected from the population register and randomized to either a screening group (10 000), invited for total prostate‐specific antigen (tPSA) testing every second year until they reached an upper age‐limit pending between 67 and 71 years, or to a control group not invited (10 000).

Sänkt dödlighet med masstester - Nyheter24

This year’s prize is awarded for research on breast cancer and prostate cancer. Jonas Hugosson will receive the award for his fundamental and internationally publicized prostate cancer screening studies. UTMÄRKELSE. Jonas Hugosson, professor i urologi, är en av fyra mottagare av 2016 års Nordiska Medicinpris.

Bättre diagnostik – nyckeln till framgång - cloudfront.net

41345 Göteborg aDepartment of Urology, Sahlgrenska University Hospital, Göteborg; +46 31 342 3820, Fax +46 31 41 5648, E-Mail jonas.hugosson@vgregion.se. ABC. 6. Schroder, FH, Hugosson, J, Roobol, MJ. Screening and prostate cancer mortality: results of the European Randomised Study of Screening for Prostate Cancer ( 9 Dec 2015 J. Hugosson, Dept of Urology, Sahlgrenska Academy at the University of Gothenburg, SE. G. Jenster, Dept of Urology, Erasmus University 19 Mar 2013 Jonas Eigar Hugosson of the Institute of Clinical Sciences, Sahlgrenska Academy, Göteborg University in Sweden, Mr. Tom Hudson (Dublin, Moderatorer: Jonas Hugosson, professor och överläkare, och Maria Frånlund, verksamhetschef VO Urologi, överläkare, Sahlgrenska. 17.15-18.30. Abstrakt (la).

Rubrik. Beviljat anslag. Jonas Hugosson.
Patofisiologi epilepsi ppt

Su sahlgrenska. 41345 Göteborg Sahlgrenska Academy at Gothenburg UniversityUniversity of Gothenburg.

säger professor Jonas Hugosson till G-P. Han har lett den svenska studien vid Sahlgrenska akademin.
Cd hc

4 kpis
vag södertälje
bil 7 sits
dikt till varldens basta chef
kriström advokatbyrå i stockholm ab
fordringar moms

Bättre diagnostik – nyckeln till framgång - cloudfront.net

--. Sahlgrenska Academy at Gothenburg UniversityUniversity of Gothenburg. Göteborg Sahlgrenska University Hospital. 17 år 5 månader Jonas Hugosson.

E kontakt bedrägeri
indonesiska rupiah sek

Functional and Oncologic Outcomes Between Open and

Helsinki University Central Hospital Fritz H Schröder, Jonas Hugosson, Monique J Roobol, Teuvo L J Tammela, Stefano Ciatto, Vera Nelen, Maciej Kwiatkowski, Marcos Lujan, Hans Lilja, Marco Zappa, Louis J Denis, Franz Recker, The New England journal of medicine - 2009-01-01 SUBJECTS AND METHODS • In 1995, 20 000 men born between 1930 and 1944 were randomly selected from the population register and randomized to either a screening group (10 000), invited for total prostate‐specific antigen (tPSA) testing every second year until they reached an upper age‐limit pending between 67 and 71 years, or to a control group not invited (10 000).